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The title compound, C9H8BrN3O2, crystallizes with two almost
identical molecules in the asymmetric unit. The crystal packing
is stabilized by N—H  N hydrogen bonds and – stacking
interactions.
Comment
2,5-Disubstituted 1,3,4-oxadiazole derivatives possess a wide
range of biological activities, such as antibacterial, antifungal,
antimalarial, anticonvulsant, central nervous system depres-
sant, anti-inflammatory and anticancer properties (Jones et al.,
1965; Adelstein et al., 1976; Zarghi et al., 2005). The anti-
inflammatory and analgesic activities of 1,3,4-oxadiazole
derivatives have been extensively studied in recent years
(Andreani et al., 1994; Misra et al., 1996; Amir & Shikha,
2004). We have recently reported the anti-inflammatory
activity of 2,5-disubstituted 1,3,4-oxadiazole derivatives
(Narayana, Ashalatha et al., 2005, or Narayana, Vijaya Raj et
al., 2005?). Because of the important biological applications of
2,5-disubstituted-1,3,4-oxadiazole derivatives, the title
compound, (I), has been synthesized and its crystal structure is
reported here.
A perspective view of the asymmetric unit (two molecules)
of compound (I) is shown in Fig. 1. Bond lengths and angles
can be regarded as normal (Cambridge Structural Database,
Version 5.27, November 2005, updated August 2006;
MOGUL, Version 1.1; Allen, 2002). Both molecules are
essentially planar (r.m.s. deviations for all non-H atoms 0.115
and 0.043 A˚ for the two different molecules in the asymmetric
unit). The two molecules are almost identical (r.m.s. deviation
for all non-H atoms 0.144 A˚).
The crystal packing of (I) is stabilized by N—H  N
hydrogen bonds (Table 1) and by – stacking interactions
with the following distances: centroid(ring C11–
C16)  centroid(ring C1/O1/N1/N2/C2)i = 3.601 A˚ and
centroid(ring C11A–C16A)  centroid(ring C1A/O1A/N1A/
N2A/C2A)ii = 3.441 A˚ [symmetry codes: (i) 1  x, 1  y, 1  z;
(ii) 2  x, 1  y, 2  z].
Experimental
2-Bromo-5-methoxybenzoic acid hydrazide (4.9 g, 0.02 mol) and
cyanogen bromide (2.3 g, 0.022 mol) in methanol (30 ml) were
refluxed over a water bath for 4 h. The reaction mixture was then
cooled and made alkaline using 5% sodium bicarbonate solution. The
solid which separated was filtered off and purified by recrystallization
from acetone. The title compound was obtained as white crystals from
acetone (yield 93%; m.p. 453 K).
Crystal data
C9H8BrN3O2
Mr = 270.09
Monoclinic, P21=c
a = 18.1501 (19) A˚
b = 10.3513 (7) A˚
c = 11.0955 (10) A˚
 = 95.298 (8)
V = 2075.7 (3) A˚3
Z = 8
Dx = 1.729 Mg m
3
Mo K radiation
 = 3.94 mm1
T = 173 (2) K
Block, colourless
0.47  0.36  0.21 mm
Data collection
Stoe IPDS II two-circle
diffractometer
! scans
Absorption correction: multi-scan
(MULABS; Spek, 2003; Blessing,
1995)
Tmin = 0.215, Tmax = 0.441
10488 measured reflections
3644 independent reflections
2876 reflections with I > 2(I)
Rint = 0.079
max = 25.0

Refinement
Refinement on F 2
R[F 2 > 2(F 2)] = 0.073
wR(F 2) = 0.220
S = 1.05
3644 reflections
274 parameters
H-atom parameters constrained
w = 1/[2(Fo
2) + (0.1458P)2
+ 1.2938P]
where P = (Fo
2 + 2Fc
2)/3
(/)max < 0.001
max = 1.77 e A˚
3
min = 1.42 e A˚3
Extinction correction: SHELXL97
(Sheldrick, 1997)
Extinction coefficient: 0.021 (2)
Table 1
Hydrogen-bond geometry (A˚, ).
D—H  A D—H H  A D  A D—H  A
N3—H3A  N2Ai 0.88 2.28 3.043 (9) 145
N3—H3B  N1ii 0.88 2.24 3.067 (8) 158
N3A—H3A1  N2iii 0.88 2.27 3.015 (9) 142
N3A—H3A2  N1Aiv 0.88 2.19 3.043 (8) 162
Symmetry codes: (i) xþ 2; yþ 12;zþ 32; (ii) x;yþ 32; zþ 12; (iii)xþ 2; y 12;zþ 32; (iv) x;yþ 12; zþ 12.
H atoms were found in a difference map but were subsequently
positioned geometrically and allowed to ride on their parent atoms at
distances of 0.88, 0.95 and 0.98 A˚ for N-bound H, aromatic H and
methyl H, respectively. The methyl groups were allowed to rotate but
not to tip. Uiso(H) was set to 1.2Ueq(C,N) or 1.5Ueq(Cmethyl). The
highest peak is 0.99 A˚ from Br1A and the deepest hole is 1.14 A˚ from
Br1A.
Data collection: X-AREA (Stoe & Cie, 2001); cell refinement:
X-AREA; data reduction: X-AREA; program(s) used to solve
structure: SHELXS97 (Sheldrick, 1997); program(s) used to refine
structure: SHELXL97 (Sheldrick, 1997); molecular graphics: XP in
SHELXTL-Plus (Sheldrick, 1991); software used to prepare material
for publication: SHELXL97.
One of the authors (BVA) thanks Mangalore University for
permission to carry out the research work.
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Figure 1
A perspective view of the two molecules in the asymmtric unit of (I), with
the atom numbering. Displacement ellipsoids are drawn at the 50%
probability level.
